[Consensus on pegylated interferon alpha in treatment of chronic hepatitis B]
Zhonghua Gan Zang Bing Za Zhi
.
2017 Sep 20;25(9):678-686.
doi: 10.3760/cma.j.issn.1007-3418.2017.09.007.
[Article in Chinese]
Authors
W H Zhang
1
,
D Z Zhang
2
,
X G Dou
3
,
Q Xie
4
,
J J Jiang
5
,
X Y Chen
6
,
H Ren
2
Affiliations
1
Huashang Hospital of Fudan University, Shanghai 200040, China.
2
The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
3
Shengjing Hospital of China Medical University, Shenyang 110002, China.
4
Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
5
First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
6
YouAn Hospital, Capital Medical University, Beijing 100069, China.
PMID:
29108190
DOI:
10.3760/cma.j.issn.1007-3418.2017.09.007
No abstract available
Keywords:
Consensus; Hepatitis B, chronic; Interferons; Therapy.